Navigation Links
Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland
Date:2/4/2008

BASEL, Switzerland, February 4 /PRNewswire/ -- Synosia Therapeutics today announced the appointment of Philippe Lutz MA Finance, as the company's first chief financial officer, effective immediately. He will be based at Synosia's new headquarters in Basel, Switzerland.

Lutz joins Synosia from Credit Suisse Investment Banking where he most recently served as a vice president of the global markets solutions group. In a nine-year career at Credit Suisse, he contributed to a broad range of capital market transactions and successfully completed the chartered financial analyst exams (CFA). Lutz is a Swiss national and earned his masters in business administration from the University of St. Gallen.

"Since Synosia started operations just over two years ago, we've established partnerships with Roche, Novartis and Syngenta, designed and completed our first clinical trial, prepared to start four phase II trials later this year, and built strong teams in both San Francisco and Basel," said the company's Chief Executive Officer and President Ian Massey.

"The establishment of our corporate headquarters in Switzerland and the appointment of Philippe Lutz is a further step in our progression to a mature development organization; it also underscores the importance of Switzerland as a centre of excellence for the management, clinical development and extension of our portfolio of compounds," Dr Massey continued.

"I knew that Synosia was the company I wanted to join once I met the management team and saw the extraordinary progress the company has made," said Lutz. "I was also pleased to learn of the new headquarters in Switzerland. The strength of Switzerland's pharmaceutical sector should help sustain Synosia's ambitious development programme."

About Synosia Therapeutics

Synosia Therapeutics develops and intends to commercialize innovative and clinically differentiated products for unmet medical needs in psychiatry and neurology. The pr
'/>"/>

SOURCE Synosia Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
2. Synosia Therapeutics Announces Appointment of Chief Business Officer
3. Taligen Therapeutics Secures Series B Financing
4. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
5. CV Therapeutics to Host Investor Science Day on Thursday, February 7, 2008
6. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
7. Amsterdam Molecular Therapeutics to Appoint Philippe van Holle (Celgene) to Supervisory Board
8. CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008
9. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
10. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
11. Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... German . , The ... a semiconductor layer. Quantum dots are small structures that spontaneously ... short laser pulse is fired at the photonic crystal, its ... change in the electromagnetic field around it. This change can ... the dot. As soon as the refractive index recovers its ...
(Date:9/30/2014)... Sept. 30, 2014 Pacific Northwest Biotechnology, ... Summary Global Markets Direct,s, ,Pacific Northwest Biotechnology, ... an overview of the Pacific Northwest Biotechnology, LLC,s ... provides comprehensive information on the current therapeutic developmental ... comparative analysis at various stages, therapeutics assessment by ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Over the ... primarily due to rising R&D budgets and increased acceptance ... fast growing pharmaceutical and biotechnology industries are also catalyzing ... laboratory filtration market is expected to grow at a ... is estimated to be worth $2,532.6 million by 2019. ...
(Date:9/30/2014)... 30, 2014 CORD:USE Cord Blood Bank – ... it has entered into an Equity and Exclusive Services ... licensed a series of patented technologies for the isolation of ... applications.  Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4
... online today in Genome Research ( www.genome.org ... the genes and pathways associated with aging. This ... simple model organisms that may lead to the characterization ... and age-associated diseases. , While nearly all organisms experience ...
... to the electronics industrys rallying cry of smaller and ... are likely to come from microchips and data storage ... molecules and polymers. With innovative measurement techniques and new ... the March Meeting of the American Physical Society how ...
... GPRO ) announced today that the Company will present ... Miami Beach on March,18, 2008 at approximately 3:15 p.m. ... Healthcare Conference in Boston on March 19, 2008 at,approximately ... webcast live and may be accessed through a link ...
Cached Biology Technology:Growing old together: Yeast, worms and people may age by similar mechanisms 2Copolymers block out new approaches to microelectronics at NIST 2Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences 2
(Date:9/30/2014)... What do seedless watermelon, salmon, and strawberries all have ... have two sets of chromosomes and are diploid, these ... more sets of chromosomesseedless watermelon and salmon have 3 ... 10! While this might seem surprising, in fact ... was first discovered over a century ago, but only ...
(Date:9/30/2014)... (PCE) in drinking water may increase the risk ... new study led by a Boston University School ... in the journal Environmental Health , compared ... 1,766 women in Cape Cod, Ma., where water ... early 1980s by the installation of vinyl-lined asbestos ...
(Date:9/30/2014)... to using marijuana, new research, involving mice and published ... Journal of Leukocyte Biology , suggests that just ... should. That,s because a team of Italian scientists have ... long-term damage to the immune system. This damage may ... as multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis ...
Breaking Biology News(10 mins):Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4Contaminated water linked to pregnancy complications, BU study finds 2Adolescent exposure to thc may cause immune systems to go up in smoke 2
... 6, 2007) - The American Society of Plant Biologists (ASPB) ... awards were presented at the societys annual meeting that was ... as the American Fern Society and the American Society of ... a list of the 2007 award winners in 10 different ...
... each cell, a little engine called RNA polymerase II does ... nucleus that get carried to production units in the rest ... at the University of Michigan Medical School have shown that ... damage. When certain types of damage in DNA halt the ...
... Moray eels have a unique way of feeding reminiscent of ... After seizing prey in its jaws, a second set of ... mouth, grabs the food and carries it back to the ... for feeding behavior for fishes in general," said Rita Mehta, ...
Cached Biology News:The American Society of Plant Biologists announces 2007 awards 2The American Society of Plant Biologists announces 2007 awards 3The American Society of Plant Biologists announces 2007 awards 4The American Society of Plant Biologists announces 2007 awards 5Enzyme alerts cell's powerful army to repair DNA damage 2Enzyme alerts cell's powerful army to repair DNA damage 3'Alien' jaws help moray eels feed 2
...
... With increasing age, the autofluorescent pigment ... many cell types, including neurons. The ... the use of fluorescence microscopy in ... its broad excitation and emission spectra, ...
Purified anti-LAT...
Polyclonal Antibody to AHI1 / Jouberin...
Biology Products: